Suppression of vascular endothelial growth factor expression in breast cancer cells by microRNA-125b-mediated attenuation of serum amyloid A activating factor-1 level

Oncoscience
Alpana Ray, Bimal K Ray

Abstract

Increased level of an inflammation-responsive transcription factor called serum amyloid A-activating factor (SAF-1) has been linked to the pathogenesis in human breast cancer. SAF-1 is found to promote vascular endothelial growth factor (VEGF) expression in breast carcinoma cells and boost angiogenesis. In an effort to develop a cellular mechanism to control VEGF expression, we sought to limit SAF-1 activity in breast cancer cells. We report here several targets within the SAF-1 mRNA for binding of microRNA-125b (miR-125b) and we show that VEGF expression is reduced in breast cancer cells when SAF-1 level is reduced with the microRNA action. Within the 3' un-translated region (UTR) of SAF-1 transcript, we have identified four highly conserved miR-125b responsive elements. We show that these miR-125b binding sites mediate repression of SAF-1 by miR-125b. Ectopic expression of miR-125b in nonmetastatic and metastatic breast cancer cells repressed SAF-1-mediated activity on VEGF promoter function and inhibited cancer cell migration and invasion potentials in vitro. Together, these results suggest that termination of SAF-1 function by miR-125b could be developed as a potential anti-VEGF and anti-angiogenic agent, which has high cli...Continue Reading

References

Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S A BossoneK B Marcu
Sep 1, 1996·Scientific American·J Folkman
Feb 1, 1997·Endocrine Reviews·N Ferrara, T Davis-Smyth
Jan 23, 1999·The Journal of Biological Chemistry·F Karantzoulis-FegarasP A Marsden
Sep 21, 2000·The Journal of Biological Chemistry·A RayB K Ray
Oct 3, 2002·Nature Reviews. Cancer·Robert Kerbel, Judah Folkman
Feb 7, 2003·Current Pharmaceutical Design·N M MazureJ Pouysségur
Sep 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alpana RayBimal K Ray
Dec 9, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ilse Van der AuweraLuc Y Dirix
Aug 17, 2005·Cancer Research·Marilena V IorioCarlo M Croce
Mar 25, 2006·Nature Reviews. Cancer·Aurora Esquela-Kerscher, Frank J Slack
Aug 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alpana RayBimal K Ray
Nov 18, 2006·The Journal of Biological Chemistry·Gary K ScottChristopher C Benz
Jan 24, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bimal K RayAlpana Ray
Sep 29, 2007·Breast Cancer Research and Treatment·Xin WangMichael W Kilgore
Dec 7, 2007·Proceedings of the National Academy of Sciences of the United States of America·Xu-Bao ShiRalph W deVere White
Mar 10, 2009·Gene·Marcus SohlFilip Farnebo
Jul 14, 2009·The Journal of Pathology·Raffaele BaffaAnne Rosenberg
Mar 3, 2010·Genes & Development·Jan-Henning KlusmannDirk Reinhardt
Feb 7, 2012·Cell Structure and Function·Shiva AkhavantabasiAyse Elif Erson-Bensan
Mar 1, 2012·Proceedings of the National Academy of Sciences of the United States of America·Aadel A ChaudhuriDavid Baltimore
Jan 17, 2013·Journal of Hematology & Oncology·Yu-Meng SunYue-Qin Chen

❮ Previous
Next ❯

Citations

Dec 18, 2020·Cell Proliferation·Boya PengMinh T N Le

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
FCS
PCR
Assay
electrophoresis

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.